Clinical Trial Update: Efficacy of Albuterol SPIROMAX® in Adult and Adolescent Patients With Exercise-Induced Bronchoconstriction (EIB) [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing the efficacy of SPIROMAX albuterol for exercise-induced bronchoconstriction in adults and adolescents has completed, with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Exercise-induced Bronchoconstriction

Drugs mentioned

• SPIROMAX Albuterol (albuterol)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Exercise-Induced Bronchoconstriction (EIB) | Phase 3 | Status: COMPLETED | Results posted: 2015-05-19